Vivosim
VivoSim Labs, Inc. (formerly Organovo Holdings, Inc., rebranded April 2025) is a San Diego-based biotechnology company specializing in AI-driven, 3D bioprinted human tissue models for drug discovery and toxicology. They provide NAMkind™ liver and intestine models to help pharmaceutical partners predict human, non-animal toxicological outcomes.
